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Background: Globally, the population is ageing and lives with several chronic diseases for decades. A high
symptom burden is associated with a high use of healthcare, admissions to nursing homes, and reduced quality of
life. The aims of this study were to describe the multidimensional symptom profile and symptom burden in
community-dwelling older people with multimorbidity, and to describe factors related to symptom burden.
Methods: A cross-sectional study including 378 community-dwelling people ≥ 75 years, who had been
hospitalized ≥ 3 times during the previous year, had ≥ 3 diagnoses in their medical records. The Memorial Symptom
Assessment Scale was used to assess the prevalence, frequency, severity, distress and symptom burden of 31
symptoms. A multiple linear regression was performed to identify factors related to total symptom burden.
Results: The mean number of symptoms per participant was 8.5 (4.6), and the mean total symptom burden score
was 0.62 (0.41). Pain was the symptom with the highest prevalence, frequency, severity and distress. Half of the
study group reported the prevalence of lack of energy and a dry mouth. Poor vision, likelihood of depression, and
diagnoses of the digestive system were independently related to the total symptom burden score.
Conclusion: The older community-dwelling people with multimorbidity in this study suffered from a high symptom
burden with a high prevalence of pain. Persons with poor vision, likelihood of depression, and diseases of the
digestive system are at risk of a higher total symptom burden and might need age-specific standardized guidelines
for appropriate management.
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Chronic conditions among older people represent some
of the largest health care challenges of this century, and
one which will affect both the socioeconomics and the
health care system [1]. Globally, the population is ageing
and people can now live with several chronic diseases
for decades [2]. Chronic diseases tend to increase with
old age. An international systematic review reported that
approximately 62% of all the people aged between 65–74
years, and 81.5% of people above 85 years suffer from
multiple chronic diseases [3]. A co-occurrence of ≥2* Correspondence: jeanette.eckerblad@liu.se
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timorbidity [4]. Multimorbidity is a condition with a
high impact on functional impairment and quality of life
[5,6], and is a condition that often results in a variety of
different symptoms [7].
In a number of studies, older people have been repor-
ted to suffer from various symptoms. These reports have
been based on measurements of a single symptom such
as depression [8] fatigue [9], sleep disorder [10] or pain
[11]. Other studies have been based on only one symptom
dimension, usually intensity or severity [12,13]. The use of
a multidimensional approach with the aforementioned
dimensions is advocated both in research [14] and clinical
practice [15]. A multidimensional assessment may also
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Figure 1 Flow chart of the inclusion and exclusion process
of participants.
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ness of interventions [16]. Symptom burden is a complex
concept that goes beyond the scoring of any symptom
instrument. To persons suffering from an advanced dis-
ease the impact of symptoms is often a well-known [17].
In an older population, high symptom burden is associ-
ated with increased health care utilization, frequent visits
to the emergency department, hospitalization [18], admis-
sions to nursing homes [19], and reduced quality of life
[20,21]. Symptom burden has been defined in different
ways. In this study symptom burden is defined as “the
subjective, quantifiable prevalence, frequency, and severity
of symptoms placing a physiological burden on patients
and producing multiple negative, physical, and emotional
patient responses” [22].
Earlier studies within the research field of multidimen-
sional symptoms have usually been conducted on spe-
cific chronic diseases, for example chronic obstructive
pulmonary disease (COPD), heart failure (HF) or renal
disease [20,21,23], and there is a paucity of studies fo-
cusing on multidimensional symptoms in older persons
with multimorbidity. Existing guidelines for disease
management are disease-specific, and they are not de-
signed for people with multimorbidity [24]. If we set out
to reduce the impact of diseases by reducing the symp-
tom frequency, minimizing symptom severity, and re-
lieving symptom distress it is essential to look at and
assess the total symptom burden, not just one disease at
the time.
Aims
The aims of this study were to describe the multidi-
mensional symptom profile and symptom burden of
community-dwelling older people with multimorbidity.
An additional aim was to describe which factors are re-
lated to symptom burden.
Methods
Design
This is a cross-sectional study using baseline data
from a randomized controlled trial intended to include
community-dwelling older people with multimorbidity
and who had a great need for health care during the
preceding year [25].
Participants
Participants were recruited from one municipality through
the patient administrative system of the County Council.
Norrkoping is a middle-sized city, (120 000) in the south-
east of Sweden, where approximately 9% of the inhabi-
tants are ≥75 years. Inclusion criteria were: people ≥
75 years, who had been hospitalized ≥ 3 times during the
previous year, who had ≥ 3 diagnoses in their medical
records according to the International classification ofdiseases (ICD-10) [18] and who lived at home. The only
exclusion criterion was if participants were already living
in a nursing home. Eight hundred forty-four older people
were invited to participate; of those, 79 were excluded
since they had moved to a nursing home just before the
study started, 26 were deceased, 32 could not be reached,
and 304 declined to participate. Out of the 403 that were
willing to participate, in 22 cases written informed consent
was missing and they were therefore excluded. In the
present study, only those who had completed the symp-
tom assessment instrument were included; in total 378 eli-
gible participants. The flow-chart of the study is visualized
in Figure 1.
Procedures
An invitation letter explaining the purpose of the study
was sent to the eligible older people. They were then
contacted by telephone, and those who gave oral infor-
med consent were scheduled for an appointment at their
home for protocolled directed interviews during which
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with protocol-guided interviews, performed by specially
trained registered nurses or occupational therapists be-
tween February 2011 and December 2011. The study
followed the ethical guidelines given in the declaration
of Helsinki and was approved by the regional ethical
review board in Linkoping (Dnr. 2011/41-31).
Assessments
Symptoms
Symptom prevalence, symptom experience and symp-
tom burden were assessed using the Memorial Symptom
Assessment Scale (MSAS) [15]. MSAS includes a large
number of commonly occurring symptoms and assesses
the prevalence of 32 symptoms. It considers symptoms
experienced during the preceding week in terms of three
dimensions - frequency, severity and distress - for 24
symptoms, and two dimensions - severity and distress -
for eight symptoms. The format for responses is as
follows. The prevalence of each symptom is answered by
yes/no: frequency on a four-point scale - rarely, occa-
sionally, frequently or almost constantly; severity on a
four-point scale - slight, moderate, severe, or very severe;
and distress on a five-point scale - not at all, a little bit,
somewhat, quite a bit or very much [26]. For clarity of
reporting, we used the terms ‘high frequency’, ‘high
severity’ and ‘high distress’ for the two highest scores of
each symptom dimension. One item dealing with sexual
interest or activity was excluded from the original instru-
ment prior to the data collection. The data collector did
not feel comfortable asking the old and often lonely
people a question about sex. This left the instrument
with 31 symptoms. The coding of the instrument was
based upon the instruction of the original authors [26].
The symptom burden score was calculated as a mean
score of frequency, severity and distress of each symp-
tom [15]. The total symptom burden score per patient
(TMSAS) is the mean of all 31 symptom burden scores
[26]. The MSAS was originally conducted to assess
symptoms in people with cancer [26] but has since been
tested and evaluated on people with different chronic
diseases [20,21,27]. The MSAS is validated and has been
used in a Swedish context [28,29]. The Cronbach’s alpha
coefficient for TMSAS in this study was 0.82.
Background characteristics
Background data collected in this study included age,
gender, current marital status, living situation, next of
kin, education level, use of tobacco and alcohol, prob-
lems with vision, hearing, and body mass index (BMI).
Cognitive decline was measured by the Mini-Mental
State Examination (MMSE), which is a validated 30-point
brief questionnaire test that is used to screen for cognitive
impairment. In this test, 24 points or more is consideredas normal cognitive function, 18–23 is mild–moderate
cognitive dysfunction, and <18 indicates severe cognitive
dysfunction. The likelihood of depression was assessed by
using the Geriatric Depression Scale (GDS-15) [30], which
is a validated self-reported instrument. Data on the partic-
ipants’ medical diagnoses were provided by the ‘Data Care
Warehouse’, which is a population-based, administrative
database run by the County Council.
Statistical analysis
The statistical analysis is described by frequencies and
percentages for categorical variables, and continuous
data by means and standard deviations (SD) for normally
distributed data. To be able to compare results from this
study with previous research, MSAS symptom burden
scores are presented as mean (SD) even though the vari-
ables were often skewed. A multiple linear regression
analysis was performed to determine independent associa-
tions between TMSAS and the background characteristics
from Table 1. The multiple model was built by entering
those variables that had univariate statistical significance
with a p < 0.05 in the correlation, retaining those variables
with p < 0.05 in the final regression model. All two-way
interactions were tested in the model. Data were analyzed
using PASW Statistical (SPSS) version 20. The significance
level was set at p ≤ 0.05.
Results
The mean age of the participants was 82 (4.8) years, with
an almost equal distribution of men (52%) and women
(48%) (Table 1). Significant differences were found both
regarding gender and age between people who agreed to
participate (n = 381) and those who declined, could not
be reached, had moved to nursing home, did not provide
informed consent or had recently died (n = 461). People
who agreed to participate were slightly younger than the
non-participants 82 (4.8) vs.83 (5.4) years (p = 0.024) and
more men than women accepted the invitation to par-
ticipate (p = 0.039).
In total, 51% of participants lived alone and 81% had
an educational level consisting of elementary school.
Approximately one-third (28%) reported problems with
vision, with or without glasses and (34%) reported prob-
lems with hearing, with or without hearing device. In total,
8% currently smoked and 7% drank alcohol on a daily
basis. The mean score on the MMSE was 26 (3.2), and
20% of the participants had a score below 24 that could
indicate cognitive dysfunction. With regard to depression
we found that 32% scored equal or higher than 5 on the
GDS, indicating the likelihood of depression (Table 1).
Participants in this study had three or more medical
diagnoses in their medical record. Almost all participants
(96%) had at least one disease listed in ICD chapter 9,
diseases of the circulatory system. Participants also had
Table 1 Background characteristics
N = 378
Age (yrs.), mean (SD) 82 (4.8)
Women n (%) 182 (48)
Lived alone n (%) 193 (51)
Elementary school n (%) 305 (81)
Secondary school or higher education n (%) 68 (18)
Poor hearing with or without
hearing device. n (%)
130 (34)
Poor vision with or without glasses. n (%) 104 (28)
Smokers n (%) 32 (8)
Alcohol on daily basis. n (%) 27 (7)
BMI (kg/m2) mean (SD) 26.1 (4.6)
Underweight (BMI < 18.5) n (%) 8 (2)
Normal (BMI 18.5 ≤ 24.9) n (%) 145 (38)
Overweight (BMI 25≤ 29.9) n (%) 140 (37)
Obese (BMI > 30) n (%) 60 (16)
MMSE mean (SD) 26.3 (3.2)
MMSE 20–24 n (%) 65 (17)
MMSE 10-19n (%) 12 (3)
MMSE≤ 9 n (%) 0
GDS mean (SD) 3.7 (3.0)
GDS ≥5 n (%) 120 (32)
Diagnosis according to ICD 10 Chapter
01. Certain infectious and parasitic diseases
(A00-B99) n (%)
166 (44)
02. Neoplasma (C00-D48) n (%) 158 (42)
03. Diseases of the blood and blood-forming
organs and certain disorders involving the
immune mechanism (D50-D89) n (%)
116 (31)
04. Endocrine, nutritional and metabolic
diseases (E00-E90) n (%)
187 (50)
05. Mental and behavioral disorders
(F00-F99) n (%)
127 (33)
06. Diseases of the nervous system
(G00-G99) n (%)
130 (34)
07. Diseases of the eye and adnexa
(H00-H59) n (%)
219 (58)
08. Diseases of the ear and mastoid process
(H60-H95) n (%)
142 (37)
09. Diseases of the circulatory system
(I00-I99) n (%)
362 (96)
10. Diseases of the respiratory system
(J00-J99) n (%)
210 (55)
11. Diseases of the digestive system
(K00-K93) n (%)
206 (54)
12. Diseases of the skin and subcutaneous
tissue (L00-L99) n (%)
164 (43)
13. Diseases of the musculoskeletal system
and connective tissue (M00-M99) n (%)
295 (78)
Abbreviations: BMI Body Mass Index, MMSE Mini-Mental State Examination,
GDS-15 Geriatric Depression Scale, ICD International Classification of Diseases.
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etal system (83%), diseases of the digestive system (60%)
and diseases of the eye and adnexa (58%) (Table 1).
Symptom prevalence
The mean number of symptoms per patient (total preva-
lence) was 8.5 (4.6), 30% of the participants reported 10
co-occurring symptoms or more, and three participants
(0.8%) reported no symptoms at all. In the total group of
respondents, pain was the symptom with the highest
prevalence (67%). Half of the participants (47-51%) re-
ported dry mouth, lack of energy, numbness and tingling
in the hands and feet. Almost four out of ten (36-42%)
experienced problems with feeling drowsy, dizziness,
shortness of breath, difficulty sleeping, feeling sad, and
worrying (Table 2).
Symptom experience
Pain was the symptom reported with the highest fre-
quency score, with four out of 10 participants (43%)
reporting that the symptom had occurred frequently or
almost constantly during the preceding week. Nausea
and vomiting were reported by less than 5% (Table 2).
Pain was a symptom that most participants reported
as severe. One-third (31%) of the participants gave the
symptom a high severity score (severe or very severe).
Difficulty sleeping and lack of energy were reported by
17-21% respectively as being “severe or very severe.”
(Table 2).
Pain and a lack of energy were reported with a high
symptom distress score (quite a bit or very much dis-
tress) by 35% and 25% of the respondents respectively.
Numbness and tingling in the hands and feet, dizziness,
shortness of breath and difficulty sleeping were reported
by 14–16% of the participants as causing high symptom
distress (Table 2).
Symptom burden is reported for participants who ex-
perienced the symptoms during the preceding week and
not for the total group of 378 participants. For 29 of 31
assessed symptoms, patients who reported the respective
symptom had a mean score of ≥ 2.0, and seven symp-
toms were reported to have a mean symptom burden of
more than 2.6 (Table 3). Pain had the highest symptom
burden score; the 248 patients who reported having pain
had a mean symptom burden of 2.8 (0.68). With regard
to pain we found that 45% of the 248 participants who
reported pain had a symptom burden score of ≥ 3.0
(Table 3).
Factors related to symptom burden
For the total group of participants the total symptom
burden (TMSAS) had a mean (SD) score of 0.62 (0.41).
TMSAS was significantly correlated with sex (rs = −0.16),
with women reporting a higher score than men. TMSAS
Table 2 Symptom prevalence and symptom experience in older people with multi-morbidity
Symptom experience
Symptoms Prevalence n/(%) High frequency n/(%)a High severity. n/(%)b High distress n/(%)c
N 378 (%)
Pain 253 (67) 164 (43) 117 (31) 132 (35)
Dry mouth 193 (51) 103 (27) 55 (15) 49 (13)
Lack of energy 189 (50) 122 (32) 81 (21) 94 (25)
Numbness/tingling in hands/feet 178 (47) 95 (25) 57 (15) 57 (15)
Feeling drowsy 158 (42) 52 (14) 34 (9) 38 (10)
Dizziness 156 (41) 65 (17) 59 (16) 61 (16)
Difficulty sleeping 153 (40) 92 (24) 64 (17) 56 (15)
Shortness of breath 149 (39) 68 (18) 59 (16) 55 (15)
Feeling sad 138 (36) 46 (12) 54 (14) 48 (13)
Worrying 136 (36) 38 (10) 45 (12) 39 (10)
Swelling of arms or legs 130 (35) N/A 32 (8) 30 (8)
Cough 129 (34) 43 (11) 31 (8) 34 (9)
Itching 118 (31) 48 (13) 38 (10) 32 (8)
Problems with urination 104 (28) 71 (19) 43 (11) 44 (12)
Feeling nervous 103 (27) 36 (10) 28 (7) 31 (8)
Changes in skin 102 (27) N/A 13 (3) 18 (5)
Feeling bloated 92 (24) 45 (12) 37 (10) 34 (9)
Feeling irritable 85 (23) 25 (7) 21 (6) 18 (5)
Constipation 79 (21) N/A 33 (9) 30 (8)
Difficulty concentrating 74 (20) 21 (6) 23 (6) 25 (7)
Sweating 71 (19) 26 (7) 19 (5) 19 (5)
Lack of appetite 69 (18) 43 (11) 22 (6) 17 (4)
Diarrhea 60 (16) 22 (6) 34 (9) 30 (8)
Difficulty swallowing 54 (14) 31 (8) 25 (7) 24 (6)
Nausea 52 (14) 14 (4) 17 (5) 17 (5)
Change in the way food tastes 43 (11) N/A 10 (3) 8 (2)
Mouth sores 42 (11) N/A 14 (4) 14 (4)
Weight loss 28 (7) N/A 7 (2) 7 (2)
“I don’t look like myself” 23 (6) N/A 10 (3) 11 (3)
Hair loss 19 (5) N/A 6 (2) 6 (2)
Vomiting 14 (4) 1 (0,3) 5 (1) 5 (1)
aPercentage of people with the symptom reporting a high frequency = “frequently” or “almost constantly.” bPercentage of people with symptom reporting high
severity = “severe” or “very severe.” cPercentage of people with the symptom reporting a high distress “quite a bit” or “very much.” N/A = Not Applicable.
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hearing (rs = −0.10), with participants with poor vision
or hearing reporting higher TMSAS scores. TMSAS was
correlated with risk of depression (rs = 0.57), diseases of
mental and behavioral disorder (rs = 0.21), diseases of
the digestive system (rs = 0.16) and diseases of the
nervous system (rs = 0.11). In the multiple linear re-
gression, TMSAS was independently related to poor vision
(beta = −0.153), risk of depression (beta = 0.566), and dis-
eases of the digestive system (beta = 0.109). The R2 for this
model was 0.38, indicating that 38% of the variance ofTMSAS could be explained by these three predictors
(Table 4).
Discussion
There is a lack of knowledge concerning the multidi-
mensional symptom profile and symptom burden in
older people with multimorbidity. An important finding
of this study was that older community-dwelling people
with multimorbidity suffer a considerable symptom bur-
den, with a mean of eight symptoms per person, and
some people even reporting 10 symptoms. Almost seven
Table 3 MSAS symptom burden score of older people
who reported the symptom as present during the
previous week






Pain 248 2.8 (0.68)
Lack of energy 191 2.7 (0.67)
Difficulty swallowing 53 2.7 (0.73)
“I don’t look like myself” 22 2.7 (1.03)
Difficulty sleeping 152 2.6 (0.70)
Problems with urination 103 2.6 (0.76)




Shortness of breath 146 2.5 (0.67)
Feeling sad 135 2.5 (0.72)
Feeling bloated 90 2.5 (0.65)
Constipation 79 2.5 (0.72)
Dry mouth 189 2.4 (0.74)
Dizziness 151 2.4 (0.79)
Worrying 135 2.4 (0.64)
Feeling nervous 102 2.4 (0.72)
Difficulty concentrating 75 2.4 (0.67)
Lack of appetite 67 2.4 (0.67)
Itching 114 2.3 (0.76)
Sweating 67 2.3 (0.80)
Mouth sores 41 2.3 (0.87)
Feeling drowsy 151 2.2 (0.66)
Cough 125 2.2 (0.66)
Nausea 51 2.2 (0.62)
Hair loss 19 2.2 (0.91)
Vomiting 14 2.2 (0.32)
Swelling of arms or legs 126 2.1 (0.80)
Feeling irritable 82 2.1 (0.72)
Change in the way
food tastes
41 2.1 (0.76)
Weight loss 24 1.9 (0.97)
Changes in skin 97 1.8 (0.72)
The MSAS symptom burden score is the mean score of the three dimensions:
frequency, severity and distress.
Table 4 Dependent Variable TMSAS N = 378
Independent variables Unstandardized β Standardized
beta
P level







Multiple linear regression analysis of the dependent TMSAS and the
independent poor vision, likelihood of depression, diseases of the digestive
system in 378 older people with multimorbidity.
R square 0.38 P < 0.05.
Abbreviation: TMSAS Total Memorial symptom assessment scale.
Poor vision = self-reported, Likelihood of depression = Geriatric Depression
Scale ≥5, Diseases of the digestive system = participants with ICD (K00-K93) in
their medical record.
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the symptom with the highest frequency, severity, and
distress and had the highest symptom burden score of
all 31 symptoms. Three factors were found to be inde-
pendently associated with total symptom burden: poor
vision, likelihood of depression, and diseases of the di-
gestive system.Almost seven out of 10 participants in this study had
experienced pain during the preceding week, which is a
high number but in line with some other studies in
which community-dwelling older people reported a pain
prevalence of between 20 to 79% [31,32]. As reflected by
the high symptom burden, our findings show that pain
causes older people a considerable amount of suffering.
This group of older people living in a home had a bur-
den of pain that was comparable to the scores of hospi-
talized cancer patients near the end of life [27], which
was not something we had expected. Earlier studies de-
scribed pain as underdiagnosed and undertreated [31,33]
and found that, irrespective of clinical diagnosis, 25% of
older people do not receive analgesic treatment for pain,
and people older than 85 are even less likely to receive it
[33]. At the same time, polypharmacy is a huge problem
within the group of older people with multimorbidity;
inappropriate drug intake causes complications and
symptoms, leading to repeated visits to the emergency
department and hospitalization [34]. There has been a
lack of age-specific standardized management guidelines
for geriatric pain, and health professionals have felt that
multimorbidity complicates appropriate management
[35]. Just recently, new guidance for treating pain in the
elderly was published [31].
In addition to pain, lack of energy, difficulty swallow-
ing, “I don't look like myself”, difficulty sleeping, prob-
lems with urination, and diarrhea had a high symptom
burden in those who experienced them. These symp-
toms seem rather non-specific, that is, not related to one
specific medical diagnosis, and are not always recognized
as being important. However, earlier studies have shown
that older people with a high symptom burden have a
poorer quality of life and higher use of health services
[18,19]. To facilitate and improve symptom manage-
ment, health care providers should not only look at and
assess disease-specific symptoms but also take general
symptoms into consideration.
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sion, and diseases of the digestive system were associated
with total symptom burden. It is known that people in a
depressive mood experience a higher symptom burden
than those who are not [36]. Earlier studies have con-
firmed the association between depression and pain [37].
If recognized and treated, depression is often reversible,
but if left untreated, depression may result in the onset
of physical, cognitive, functional, and social impairment,
as well as decreased quality of life, [38] and higher mor-
tality [39]. The independent relationship between poor
vision and the total symptom burden scale has not pre-
viously been described, but other studies have reported
that people with poor hearing or vision are more likely
to experience disability, and that there are associations
between poor vision, poor hearing and depression [40].
Earlier studies have shown that people with diseases of
the digestive system have a lower health-related quality
of life [41,42] and that the severity of the gastro-
intestinal symptoms and health-related quality of life are
associated [41]. Reflecting on the high symptom burden
in multimorbid older people, we observe that in our
current health care system most care is organized from a
single disease perspective, an arrangement into which
older people with multimorbidity do not quite seem to
fit [6]. These older people have reported feeling unwel-
come or even like a burden when they need to seek care
[43]. However, health care providers still have the respon-
sibility to give patients optimal support to restore or at
least achieve an acceptable level of symptom relief [44]. A
routine of a broad assessment of symptoms and symptom
burden (not restricted to the disease-specific burden)
might lead to better symptom management [19,45] which
could maintain independence and functional ability, and
sustain or improve quality of life for older people with
multimorbidity.
Strengths and limitations
The strength of this study is that all data are assessed by
protocol-guided interviews, leaving us with little missing
data. However, there is still a risk that the older people’s
symptom experience or burden have been underestimated
since studies have shown that when questionnaires are
self-administered instead of interviewer-administered the
scores tend to be higher, so this should be taken into
consideration when the scores are interpreted [46,47]. We
also realize that this is a rather small cross-sectional study,
with participants recruited from only one city and with a
higher percentage of men than in the general population
[48]. The result of this study cannot be generalized to all
community-dwelling older people, since they represent a
unique group with many diseases. Nevertheless, the result
ought to be generalizable to groups with similar condi-
tions and living in a similar context. Another limitation ofthis study is the lack of data on diseases from all the ICD
chapters. Data on diseases would have made it possible to
identify disease clusters and use these to predict TMSAS
or to describe the symptom experience of specific clusters.
However, we still believe that although clustering of dis-
eases is important and an area of interest for future stud-
ies, our results bring forward the unique perspective of an
elderly population with several diseases living with a high
symptom burden.
Conclusion
A large proportion of the older people with multimor-
bidity living in the community suffer from a high symp-
tom burden and a high prevalence of pain. These people
have an unmet need for optimized treatment focusing
on the assessment, management and maintenance of the
total symptom burden. People with poor vision, likeli-
hood of depression and diseases of the digestive system
are at risk of facing a higher symptom burden and might
need age-specific standardized guidelines for appropriate
management.
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